Effective drug discovery in Chagas disease-Reference-Cited by-同舟云学术

Effective drug discovery in Chagas disease

Published:2023-06 Issue:6 Volume:39 Page:423-431
ISSN:1471-4922
Container-title:Trends in Parasitology
language:en
Short-container-title:Trends in Parasitology

Author:

Tarleton Rick L.^ORCID

Funder

National Institutes of Health

Wellcome Trust

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology

Reference46 articles.

1. Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates;Padilla;Nat. Microbiol.,2022

2. Frequency variation and dose modification of benznidazole administration for the treatment of Trypanosoma cruzi infection in mice, dogs and non-human primates;Bustamante;bioRxiv,2023

3. Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure;Bustamante;PLoS Negl. Trop. Dis.,2022

4. A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease;Bustamante;Sci. Transl. Med.,2020

5. Delayed activation of T cells at the site of infection facilitates the establishment of Trypanosoma cruzi in both naive and immune hosts;Padilla;mSphere,2023

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pass the boron: benzoxaboroles as antiparasite drugs;Trends in Parasitology;2024-09

2. The epidemiology of Chagas disease in the Americas;The Lancet Regional Health - Americas;2024-09

3. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi;Experimental Parasitology;2024-07

4. Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range ofTrypanosoma cruziburden among chronically infected hosts and allows accurate monitoring of parasite load following treatment;2024-06-10

5. Structural investigation of Trypanosoma cruzi Akt-like kinase as drug target against Chagas disease;Scientific Reports;2024-05-02